SUPN : Analysis & Opinions
October 12, 2016Supernus Pharmaceuticals said mid-stage trials of its ADHD drug, SPN-812, showed good results. The company plans to launch ...
August 23, 2016Small- and mid-cap biotechs are attracting healthy buying interest and setting off bullish divergences that support higher ...
June 3, 2016These biotech leaders should continue to gain ground even if broad sector funds roll over and sell off.